mTORC1-USP30-LEF1级联通过线核交叉调节癌症干和恶性进展
Xiaolin Li1,2, Haowei Zhang2, Jia Li2
1School of Food and Drug Shenzhen Polytechnic University Shenzhen China.
MedComm
|November 27, 2025
概括
一种线粒体酶USP30转移到核中,通过抑制WNT信号传递来抑制三阴性乳腺癌 (TNBC) 的干细胞和转移. 这种核功能为乳腺癌提供了新的治疗途径.
科学领域:
- 细胞生物学 细胞生物学
- 分子瘤学分子瘤学
- 生物化学 生物化学
背景情况:
- USP30是一种二维基因酶,主要以线粒体功能在线粒细胞衰变中而闻名.
- 它在细胞核和癌症生物学中的作用仍然未被探索.
研究的目的:
- 为了研究USP30在癌症中的核功能.
- 阐明USP30通过哪些机制影响三阴性乳腺癌 (TNBC) 的癌症干和化学抵抗.
主要方法:
- 免疫光和细胞分离以确定USP30局部化.
- 西方涂抹和局部定向突变发生,以研究酸化和核转位.
- 共同免疫沉和体外二维基化试验用于分析蛋白质相互作用和酶活性.
- 记者测试以评估WNT信号传输.
- 在小鼠体内转移模型.
主要成果:
- USP30定位到线粒体和细胞核.
- 营养缺乏诱导USP30核转位通过抑制mTORC1-介导的酸化在血清104.4.
- 核USP30通过对TCF/LEF1进行二基化,通过联合激活剂扰乱β-catenin/LEF1复合体的形成,抑制了TNBC中的癌症干和化学抵抗.
- USP30 TNBC组织的下调与核水平降低和转移增加相关.
- 过度表达核USP30减少TNBC小鼠模型中的肺转移.
结论:
- 在TNBC中,USP30具有作为瘤抑制剂的新型核功能.
- USP30 核转位是一个受管制的过程,对于抑制WNT信号和癌症干的抑制至关重要.
- 准USP30核定位是针对乳腺癌转移的潜在治疗策略.
更多相关视频
09:40Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
3.1K
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
1.6K
相关概念视频
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Cancer Stem Cells and Tumor Maintenance
5.8K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.8K
Induced Pluripotent Stem Cells
5.3K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
5.3K
Abnormal Proliferation
5.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
PI3K/mTOR/AKT Signaling Pathway
5.2K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.2K
Interactions Between Signaling Pathways
7.1K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.1K
